Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, 340B reform, FDA drug approval.
2025 · 3rd Quarter (July 1 - Sep 30)
BRISTOL-MYERS SQUIBB COMPANY
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration - Amendment
- Posted
- Sep 17, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Filing UUID
- 2460d232-85cb-49d2-8248-36c01436bdea
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, 340B reform, FDA drug approval.
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, 340B reform, FDA drug approval.
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, 340B reform, FDA drug approval.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.